Behavioral Intervention
ENGAGE for Multiple Disabilities
N/A
Waitlist Available
Led By Joy Hammel, PhD
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Report problems with social participation
Self-identify as disabled
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up8 weeks
Awards & highlights
No Placebo-Only Group
Study Summary
This trial will examine how a community-based intervention helps people with disabilities during the pandemic, like social participation and satisfaction. Results will help inform a future trial.
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowSelect...
You report issues with engaging in social activities.
Select...
You identify yourself as having a disability.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Feasibility
Satisfaction
Secondary outcome measures
Social Participation
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: ENGAGEExperimental Treatment1 Intervention
ENGAGE uses social learning, guided problem-solving and applied skill training to promote social participation among people with disabilities within the context of the COVID-19 pandemic. This is a group intervention using a self-management framework.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ENGAGE
2013
Completed Phase 2
~180
Find a site
Who is running the clinical trial?
National Center for Advancing Translational Sciences (NCATS)NIH
274 Previous Clinical Trials
386,997 Total Patients Enrolled
University of Illinois at ChicagoLead Sponsor
572 Previous Clinical Trials
1,554,888 Total Patients Enrolled
Joy Hammel, PhDPrincipal Investigator
University of Illinois Chicago1 Previous Clinical Trials
38 Total Patients Enrolled
Media Library
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Do you have any vacancies for those interested in participating in this trial?
"It appears this trial is no longer enrolling patients, as the last update to clinicaltrials.gov was on March 27th of 2023. There are fortunately 4 other trials that are currently in need of participants at this time."
Answered by AI